Stifel Financial’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.37M | Sell |
42,967
-22,416
| -34% | -$4.65M | 0.01% | 1120 |
|
|
2026
Q1 | $14.7M | Sell |
65,383
-1,401
| -2% | -$349K | 0.01% | 761 |
|
|
2025
Q4 | $16.1M | Sell |
66,784
-1,102
| -2% | -$282K | 0.01% | 732 |
|
|
2025
Q3 | $18.6M | Sell |
67,886
-35
| -0.1% | -$9.56K | 0.02% | 663 |
|
|
2025
Q2 | $17.5M | Sell |
67,921
-2,726
| -4% | -$650K | 0.02% | 651 |
|
|
2025
Q1 | $15.8M | Sell |
70,647
-861
| -1% | -$201K | 0.02% | 658 |
|
|
2024
Q4 | $16.4M | Buy |
71,508
+14,149
| +25% | +$3.41M | 0.02% | 647 |
|
|
2024
Q3 | $14M | Buy |
57,359
+4,611
| +9% | +$1.03M | 0.01% | 728 |
|
|
2024
Q2 | $10.1M | Buy |
52,748
+4,328
| +9% | +$878K | 0.01% | 813 |
|
|
2024
Q1 | $9.59M | Buy |
48,420
+44,569
| +1,157% | +$8.17M | 0.01% | 832 |
|
|
2023
Q4 | $663K | Buy |
3,851
+706
| +22% | +$108K | ﹤0.01% | 2410 |
|
|
2023
Q3 | $465K | Sell |
3,145
-18,740
| -86% | -$3.39M | ﹤0.01% | 2527 |
|
|
2023
Q2 | $4.78M | Sell |
21,885
-893
| -4% | -$199K | 0.01% | 1067 |
|
|
2023
Q1 | $4.99M | Sell |
22,778
-10,292
| -31% | -$2.23M | 0.01% | 1018 |
|
|
2022
Q4 | $6.88M | Sell |
33,070
-2,119
| -6% | -$466K | 0.01% | 829 |
|
|
2022
Q3 | $7.68M | Sell |
35,189
-12,782
| -27% | -$2.91M | 0.01% | 744 |
|
|
2022
Q2 | $10.1M | Sell |
47,971
-1,963
| -4% | -$418K | 0.02% | 649 |
|
|
2022
Q1 | $12.1M | Buy |
49,934
+544
| +1% | +$132K | 0.02% | 641 |
|
|
2021
Q4 | $12.9M | Sell |
49,390
-1,279
| -3% | -$332K | 0.02% | 640 |
|
|
2021
Q3 | $13.4M | Sell |
50,669
-2,067
| -4% | -$565K | 0.02% | 611 |
|
|
2021
Q2 | $13M | Buy |
52,736
+195
| +0.4% | +$41K | 0.02% | 614 |
|
|
2021
Q1 | $10.2M | Sell |
52,541
-253
| -0.5% | -$50.7K | 0.02% | 647 |
|
|
2020
Q4 | $11.2M | Sell |
52,794
-1,102
| -2% | -$220K | 0.02% | 566 |
|
|
2020
Q3 | $9.24M | Buy |
53,896
+248
| +0.5% | +$45.8K | 0.02% | 564 |
|
|
2020
Q2 | $10.3M | Sell |
53,648
-2,980
| -5% | -$488K | 0.02% | 497 |
|
|
2020
Q1 | $8.35M | Buy |
56,628
+13,988
| +33% | +$2.23M | 0.02% | 497 |
|
|
2019
Q4 | $6.6M | Buy |
42,640
+7,351
| +21% | +$1.06M | 0.01% | 763 |
|
|
2019
Q3 | $4.77M | Sell |
35,289
-1,211
| -3% | -$159K | 0.01% | 851 |
|
|
2019
Q2 | $4.44M | Buy |
36,500
+2,726
| +8% | +$302K | 0.01% | 905 |
|
|
2019
Q1 | $3.51M | Buy |
33,774
+1,515
| +5% | +$156K | 0.01% | 968 |
|
|
2018
Q4 | $3.67M | Buy |
32,259
+22,110
| +218% | +$2.37M | 0.01% | 892 |
|
|
2018
Q3 | $1.17M | Buy |
10,149
+2,274
| +29% | +$249K | ﹤0.01% | 1578 |
|
|
2018
Q2 | $816K | Sell |
7,875
-625
| -7% | -$63.2K | ﹤0.01% | 1757 |
|
|
2018
Q1 | $839K | Buy |
8,500
+1,112
| +15% | +$105K | ﹤0.01% | 1685 |
|
|
2017
Q4 | $632K | Buy |
7,388
+577
| +8% | +$47.7K | ﹤0.01% | 1779 |
|
|
2017
Q3 | $524K | Sell |
6,811
-2,222
| -25% | -$170K | ﹤0.01% | 1857 |
|
|
2017
Q2 | $703K | Buy |
9,033
+3,219
| +55% | +$230K | ﹤0.01% | 1673 |
|
|
2017
Q1 | $417K | Sell |
5,814
-534
| -8% | -$36.9K | ﹤0.01% | 1920 |
|
|
2016
Q4 | $392K | Buy |
6,348
+64
| +1% | +$3.92K | ﹤0.01% | 1902 |
|
|
2016
Q3 | $408K | Sell |
6,284
-285
| -4% | -$19K | ﹤0.01% | 1829 |
|
|
2016
Q2 | $416K | Buy |
6,569
+484
| +8% | +$28.5K | ﹤0.01% | 1869 |
|
|
2016
Q1 | $351K | Buy |
+6,085
| New | +$344K | ﹤0.01% | 1750 |
|
|
2015
Q2 | – | Sell |
-5,158
| Closed | -$370K | – | 2412 |
|
|
2015
Q1 | $370K | Sell |
5,158
-2,334
| -31% | -$152K | ﹤0.01% | 1789 |
|
|
2014
Q4 | $420K | Sell |
7,492
-218
| -3% | -$11.4K | ﹤0.01% | 1704 |
|
|
2014
Q3 | $380K | Buy |
7,710
+2,079
| +37% | +$106K | ﹤0.01% | 1673 |
|
|
2014
Q2 | $285K | Sell |
5,631
-18,961
| -77% | -$940K | ﹤0.01% | 1809 |
|
|
2014
Q1 | $1.1M | Buy |
+24,592
| New | +$1.1M | 0.01% | 1028 |
|
Other funds holding RMD
Stifel Financial's RMD Position: Q2 2026 in Review
Stifel Financial reduced its ResMed (RMD) stake by 34% in Q2 2026, selling an estimated $4.65M and leaving 42,967 shares worth $8.37M. The position accounts for 0.01% of the portfolio, ranked #1120.
Stifel Financial first reported a position in RMD in Q1 2014 and has held it in 47 quarters since. The position peaked at $18.6M in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Stifel Financial held 42,967 shares of ResMed worth $8.37M as of Q2 2026.
- Stifel Financial sold 22,416 ResMed shares in Q2 2026, an estimated $4.65M.
- ResMed made up 0.01% of Stifel Financial's portfolio in Q2 2026, its #1120 holding.
- Stifel Financial first reported a position in ResMed in Q1 2014 and has held it in 47 quarters since.
- Stifel Financial's ResMed position peaked at $18.6M in Q3 2025.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.